好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Does Age Play a Role in Providing Stroke Care to Acute Ischemic Stroke Patients Via Telestroke? Providence Telestroke Network (Oregon) Experience
Cerebrovascular Disease and Interventional Neurology
P07 - (-)
236
BACKGROUND: It is known that thrombolysis rate is higher in young AIS patients compared to old aged patients. However, no such data is available for the AIS patients treated via telestroke. Since telestroke is becoming a very important tool to provide care to AIS patients in remote areas, we wanted to look at age wise difference in treatment rate of AIS patients.
DESIGN/METHODS: We retrospectively reviewed the data at 2 hub hospital and 8 telestroke partner hospitals from August 2011 to July 2012. We looked for following data points: Age <=45, 46-79, >= 80 years, NIHSS on presentation, treatment rate (thrombolysis +/- intervention), transfer rate to tertiary care center.
RESULTS: Consultations were provided to 409 patients, out of that 93 were at partner sites. Beam in rates (two way video communications through telerobot use) were not statistically different in 3 age groups, 21.7%, 20.5% and 14.6%. Mean NIHSS were 4.42+ 3.64, 6.06+ 6.6, 9.08+ 7.51 respectively in 3 age groups (p<0.001) with highest in age >= 80 . Treatment rates were not statistically different, 13%, 18.3% and 20.4% for all patients including hub and partner sites. Treatment rates were not statistically different among 3 age groups for partner sites, 14.3%, 28% and 30.6%. Transfer rate to tertiary care center was highest and significantly different for young stroke patients, 71.43%, 36.03% and 16.73% (p= 0.009). Distance of more or less than 75 miles from hub site did not make any difference in transfer rate among 3 age groups.
CONCLUSIONS: Treatment rates were not significantly different among 3 age groups treated via telestroke system. Although, strokes were more severe in old aged patients, transfer rate to hub/tertiary stroke center was highest among young stroke patients.
Authors/Disclosures
Amit Kansara, MD (Providence Stroke Center)
PRESENTER
Dr. Kansara has nothing to disclose.
Elizabeth A. Baraban, PhD, MPH (Providence Health and Services) The institution of Dr. Baraban has received research support from Boehringer Ingelheim.
Alexandra Lesko No disclosure on file
Archit Bhatt, MD No disclosure on file
Carmen Tur Gomez, MD (Hospital Vall DˆEbron) No disclosure on file
Nicholas Okon, DO (Northwest Stroke Solutions, PLLC) No disclosure on file
John Zurasky, MD (Providence) Dr. Zurasky has nothing to disclose.
No disclosure on file
Theodore J. Lowenkopf, MD Dr. Lowenkopf has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Hart Wagner. The institution of Dr. Lowenkopf has received research support from Boerhinger Inglheim. Dr. Lowenkopf has received personal compensation in the range of $500-$4,999 for serving as a Consultant with terumo medical.